Finance

Lists
Why is CRVS down ၃.၃၅%?
Dive Deeper
CRVS:NASDAQ
Corvus Pharmaceuticals Inc
၉.၅၂ US$
-၃.၃၅%
(-၀.၃၃) 1D
၉.၅၀ US$
-၀.၂၁% (-၀.၀၂၀)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRVS...
Open
၉.၈၁ US$
High
၁၀.၁၂ US$
Low
၉.၄၃ US$
Mkt. cap
၈၀.၀၈ ကုဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၁.၀၄ သန်း
52-wk high
၂၆.၉၅ US$
52-wk low
၆.၃၉ US$
EPS
-၀.၆၂ US$
Beta
၁.၄၄
Shares outstanding
၈.၄၁ ကုဋေ
No. of employees
၃၇
Open
၉.၈၁ US$
High
၁၀.၁၂ US$
Low
၉.၄၃ US$
Mkt. cap
၈၀.၀၈ ကုဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၁.၀၄ သန်း
52-wk high
၂၆.၉၅ US$
52-wk low
၆.၃၉ US$
EPS
-၀.၆၂ US$
Beta
၁.၄၄
Shares outstanding
၈.၄၁ ကုဋေ
No. of employees
၃၇
News stories
From web sources and news partners
Fortune
Fortune
·
ပြီးခဲ့သည့် ၅၂ မိနစ်
Transient Team Gathers at Nasdaq Closing Bell, Unified Around a Single Mission
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
Caught Out By Peloton Interactive’s Fall? Here’s What Bears Saw
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၂၀ မိနစ်
Earnings Scoreboard: 83% of S&P 500 early reporters beat EPS estimates as Y/Y profit growth hits 23 firms
About Corvus Pharmaceuticals Inc
CEO-
Employees၃၇
Founded၂၀၁၄
HeadquartersBurlingame, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CRVS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRVS in the last 3 months.
Highest
Current ၉.၅၂ US$
၃၃.၀၀ US$ (+၂၄၆.၆၄%)
Average
၂၉.၅၀ US$ (+၂၀၉.၈၇%)
Lowest
၂၇.၀၀ US$ (+၁၈၃.၆၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
၃၀.၀၀ US$
+၂၁၅.၁%
08/11/2026
Sean Lee CFA
H.C. Wainwright
Buy
Maintained
၂၇.၀၀ US$
+၁၈၃.၆%
08/10/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
၃၃.၀၀ US$
+၂၄၆.၆%
08/07/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
၃၃.၀၀ US$
+၂၄၆.၆%
08/07/2026
Etzer Darout
Barclays
Buy
Maintained
၂၈.၀၀ US$
+၁၉၄.၁%
08/07/2026
Paul Choi
Goldman Sachs
Buy
Maintained
၄၀.၀၀ US$
+၃၂၀.၂%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၈.၄၅ သန်း
၉.၉၄ သန်း
၁.၁၂ ကုဋေ
၁.၆၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၁၂ သန်း
၂.၂၈ သန်း
၃.၇၀ သန်း
၃.၃၃ သန်း
Operating expense
၁.၀၆ ကုဋေ
၁.၂၂ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
Total operating expenses
၁.၀၆ ကုဋေ
၁.၂၂ ကုဋေ
၁.၄၉ ကုဋေ
၁.၉၃ ကုဋေ
Operating income
-၁.၀၆ ကုဋေ
-၁.၂၂ ကုဋေ
-၁.၄၉ ကုဋေ
-၁.၉၃ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၀၂ ကုဋေ
-၁.၂၃ ကုဋေ
-၁.၃၇ ကုဋေ
-၁.၈၀ ကုဋေ
EBT excluding unusual items
-၁.၀၂ ကုဋေ
-၁.၂၃ ကုဋေ
-၁.၃၇ ကုဋေ
-၁.၈၀ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၀၂ ကုဋေ
-၁.၂၃ ကုဋေ
-၁.၃၇ ကုဋေ
-၁.၈၀ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၂
-၀.၁၅
-၀.၁၅
-၀.၁၉
Interest and investment income
၇.၃၈ သိန်း
၆.၀၃ သိန်း
၁.၇၈ သန်း
၂.၀၅ သန်း
Interest expense
-
-
-
-
Net interest expenses
၇.၃၈ သိန်း
၆.၀၃ သိန်း
၁.၇၈ သန်း
၂.၀၅ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၅ ကုဋေ
-၁.၂၂ ကုဋေ
-၁.၄၈ ကုဋေ
-၁.၉၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ